Distinguished research award
Dr Judit Villen of the University of Washington, Seattle, USA, has been presented with the American Society for Mass Spectrometry (ASMS) 2011 Research Award.
Dr Judit Villen of the University of Washington, Seattle, USA, has been presented with the American Society for Mass Spectrometry (ASMS) 2011 Research Award. Sponsored by Thermo Fisher Scientific, the annual award recognizes and supports breakthrough academic research by young scientists in the field of mass spectrometry (MS).
An independent and anonymous ASMS committee chose Dr Villen based on her research on the MS-based analysis of protein phosphorylation in single cells. Her goal is to understand the complex cellular signalling networks that impact the expression of cancers, such as human breast cancer. The early-stage research that will be supported by the award, focuses on the development of a novel interface for single-cell MS using the company’s Orbitrap LC–MS system.
“Until now, MS studies measured proteins based on the average of millions of cells, completely missing the variations between individual cells that can have substantial consequences in signalling cell growth, proliferation and differentiation, all of which play roles in the expression of diseases such as cancer,” said Ian Jardine, vice president of global R&D at the company. “Through her early-stage effort to develop an interface for single-cell mass spectrometry analysis, Dr Villen will launch an exciting new era of single-cell proteomics.”
For more information about the company’s mass spectrometry solutions visit www.thermoscientific.com/ms
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
